| GM | Gut microbiome |
| GI | Gastrointestinal |
| CTL-4 | Cytotoxic T-Lymphocyte Antigen 4 |
| PD-1 | Programmed cell death protein 1 |
| PD-L1 | Programmed death-ligand 1 |
| ICIs | Immune checkpoint inhibitors |
| PRR | Pattern recognition receptors |
| NSCLC | Non-small cell lung cancer |
| SCFAs | Short chain fatty acids |
| WGCNA | Weighted Gene Co-expression Network Analysis |
| ECOG | Eastern Cooperative Oncology Group |
| i-RECIST | Response Evaluation Criteria in Solid Tumors |
| PFS | Progression-free survival |
| OS | Overall survival |
| NR | Non-responders |
| R | Responders |
| CTRLs | Controls |
| OTUs | Operational taxonomic units |
| VOCs | Volatile organic compounds |
| GC-MS/ | Gas-chromatography-mass spectrometry/ |
| SPME | Solid phase microextraction/ |
| IS | Internal Standard |
| NMR | Nuclear magnetic resonance spectroscopy |
| TSP | Trimethylsilyl propionic acid sodium salt |
| IQR | Inter Quartile Range |
| FDR | False Discovery Rate |
| ME | Module eigengene |
| MM | Module membership |
| BS | Biomarker significance |
| CAR | Chimeric antigen receptor |
| FMT | Fecal microbiota transplantation |